A fasting C‑peptide measures the amount of C‑peptide in blood after fasting, reflecting endogenous insulin production because C‑peptide is released with insulin from pancreatic beta cells. It helps distinguish type 1 (low) from type 2 (normal/high) diabetes, assess beta‑cell function, monitor disease progression or treatment response, and evaluate unexplained hypoglycemia or suspected insulin misuse.

Best time: an early‑morning fasting sample after an overnight fast for a baseline C‑peptide. For a more sensitive measure, use a stimulated test—mixed‑meal tolerance (peak around 90 minutes) or glucagon‑stimulated testing. Ensure blood glucose isn’t hypoglycaemic (ideally >70 mg/dL) and avoid testing soon after exogenous insulin or sulfonylurea doses that can alter results.

Improve C‑peptide by preserving/restoring pancreatic beta‑cell function and reducing insulin resistance. Achieve and maintain healthy weight with a calorie‑controlled, low‑refined‑carbohydrate or Mediterranean‑style diet, regular aerobic and resistance exercise, smoking cessation, and limited alcohol. Optimize blood‑glucose control and follow prescribed diabetes medications or insulin; discuss additional therapies (e.g., GLP‑1 agonists) and regular monitoring with your clinician.

C-peptide, a marker of endogenous insulin production, is often normal or elevated in type 2 diabetes because insulin resistance drives increased insulin (and C-peptide) secretion. With long-standing disease and progressive beta‑cell failure, C‑peptide can fall and become low. Kidney function and some treatments also affect levels, so results are interpreted in the context of disease duration and clinical situation.

There’s no instant cure, but the fastest evidence-based way to reverse insulin resistance is weight loss plus increased physical activity—especially regular aerobic and resistance training—combined with dietary changes (reduce refined carbs/sugary foods, increase fiber and healthy fats). Improve sleep, manage stress, quit smoking, and, where appropriate, use metformin under medical supervision. Early, sustained changes yield the quickest improvement.

C‑peptide levels reflect endogenous insulin secretion and are affected by beta‑cell function and diabetes type (type 1 vs type 2). Levels vary with fasting versus postprandial timing, medications that stimulate insulin or exogenous insulin use, renal clearance (impaired kidneys can raise levels), insulin resistance and obesity, acute illness or stress, and patient factors such as age and pregnancy.